Microbiological Diagnosis
SEIMC: Formación Continuada | 01/04/2020
Dr. Jordi Vila Estapé. SEIMC. President. Head of Microbiology Service. Hospital Clínic, Barcelona.
How Can Remdesivir or Tocilizumab Help In Treating COVID-19?
SEIMC: Formación Continuada | 01/04/2020
Dr. Jose M. Miró. Consultant Infectious Diseases Service. Associate Professor of Medicine. Hospital Clinic - IDIBAPS. University of Barcelona.
Virological Assessment of Hospitalized Cases
SEIMC: Formación Continuada | 01/04/2020
Dr. Roman Woelfel. Institute Director Bundeswehr Institute of Microbiology, Germany.
COVID-19 Illness in Native and Immunosuppressed States
SEIMC: Formación Continuada | 01/04/2020
Dr. Mandeep R. Mehra. Department of Internal Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.
Clinical Features: Predictors of Outcome
SEIMC: Formación Continuada | 01/04/2020
Dr. Zheng Xin. Infections department of Wuhan Union Medical College Hospital.
COVID-19: Could Hydroxychloroquine Really be the Answer?
SEIMC: Formación Continuada | 01/04/2020
Dr. Oriol Mitjà. Associate Professor and Head of the STI unit at the Germans Trias i Pujol Hospital and associate researcher at ISGlobal, Barcelona.
Pathogenicity of SARS-CoV-19
SEIMC: Formación Continuada | 01/04/2020
Dr. Adolfo García Sastre. Icahn School Of Medicine, Mont Sinai, New York, USA.
Combining Antiviral and Anti-Inflammatory Drugs To Treat COVID-19
SEIMC: Formación Continuada | 01/04/2020
Effect Of Non-Pharmaceutical Interventions For Containing the COVID-19 Outbreak In China
SEIMC: Formación Continuada | 01/04/2020